Tel: +387 33 771 700 | Fax: +387 33 771 707 | apomedical@apomedical.ba | BHS | EN

Celgene, a biopharmaceutical company, was founded in 1986 in the United States, in Summit, New Jersey. The company has manufacturing facilities in the US and Europe (Germany, UK, Switzerland, Austria, Italy), and research institutes in New Jersey, California, Massachusetts, United States and Spain. In 2006 company Celgene has opened its administrative seat in the capital of the Swiss canton of Neuchatel, Boudry district, and company itself counts about 6,000 employees.

The company Celgene in its assortment includes six original medicines, including five which stands out as the only one in the world, for the treatment of nine rare and malignant diseases. These products - in the form of tablets, capsules and dust for infusion- are used to treat diseases in the field of oncology, hematology, immunology, dermatology.

Medicines, from the Celgene's product range, treat the following diseases: two types of multiple myeloma (blood cancer), myelodysplastic syndrome (MDS), acute leukemia, breast cancer, pancreatic cancer, lung cancer, psoriasis and psoriatic arthritis.

Web: https://www.celgene.com/